News
Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...
CPI inflation, retail sales, consumer sentiment, housing data, trade meetings with China, and earnings from Walmart, Cisco, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback